Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+14.84%)
As of: Nov 16, 2026 · 12:58 PM EST

Elite Pharmaceuticals (ELTP) Operating Income (2009 - 2026)

Updated

Elite Pharmaceuticals (ELTP) reported Operating Income of $9.93 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 20.8% from $8.21 million a year earlier and up 31.8% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Operating Income (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Elite Pharmaceuticals' Operating Income came in at $36.65 million, down 13.1% year-over-year; for FY2026 (ended Mar 31, 2026), it was $49.11 million, up 150.6% from FY2025.

  • Operating Income has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 87.8% (FY2021 to FY2026).
  • By fiscal year, Operating Income came in at $19.6 million in FY2025 (+81.7%), $10.79 million in FY2024 (+193.5%), $3.68 million in FY2023 (-27.5%) and $5.07 million in FY2022 (+140.9%).
  • Five-year quarterly Operating Income spans a low of -$386,899 in fiscal Q4 2023 and a high of $21.7 million in fiscal Q1 2026.
  • Year over year, Operating Income gained in five of the last eight quarters, with growth averaging 174.4%.
  • The high point for year-over-year Operating Income in five years was fiscal Q3 2026 (growth of 721.0%); the low point was fiscal Q3 2025 (a decline of 68.9%).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $7.53 million (Q1 2027), $10.19 million (Q4 2026) and $9.01 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,286.92 Bn 1,260.54 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 686.05 Bn 605.91 Bn 17.30 Bn 6.18 Bn
3 AbbVie 523.52 Bn 491.53 Bn 13.12 Bn 6.27 Bn
4 Merck 361.19 Bn 324.13 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 313.37 Bn 286.61 Bn - -
6 Astrazeneca 286.61 Bn 260.13 Bn 13.26 Bn 4.39 Bn
7 Amgen 252.56 Bn 204.21 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 210.02 Bn 185.12 Bn 6.73 Bn 3.46 Bn
9 Pfizer 164.90 Bn 112.26 Bn 12.56 Bn 5.47 Bn
10 Elite Pharmaceuticals 395.85 Mn 269.26 Mn 15.99 Mn 9.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9.93 Mn
Jun 30, 2026 7.53 Mn
Mar 31, 2026 10.19 Mn
Dec 31, 2025 9.01 Mn
Sep 30, 2025 8.21 Mn
Jun 30, 2025 21.70 Mn
Mar 31, 2025 11.15 Mn
Dec 31, 2024 1.10 Mn
Sep 30, 2024 3.48 Mn
Jun 30, 2024 3.86 Mn
Mar 31, 2024 3.73 Mn
Dec 31, 2023 3.53 Mn
Sep 30, 2023 1.93 Mn
Jun 30, 2023 1.60 Mn
Mar 31, 2023 -386,899.00
Dec 31, 2022 1.96 Mn
Sep 30, 2022 1.08 Mn
Jun 30, 2022 1.02 Mn
Mar 31, 2022 851,676.00
Dec 31, 2021 1.83 Mn
API Access

Elite Pharmaceuticals Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=ELTP&period=max&api_key=YOUR_API_KEY